Survival of childhood leukemia in Singapore

Medical and Pediatric Oncology

Volumn 26, Issue 5, 1996, Pages 318-324

  Quah, Thuan Chong ^a   Sun, Li ^a   Chew, Fook Tim ^a   Yeoh, Allen ^a   Lee, Bee Wah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

acute leukemia; acute lymphoblastic leukemia; acute myeloid leukemia; ALL; AML; DFS; disease free survival

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLEEDING; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOPHENOTYPING; INFANT; INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SINGAPORE; SKULL IRRADIATION; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HEPATOMEGALY; HUMANS; INFANT; KIDNEY FAILURE, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PROGNOSIS; RECURRENCE; SINGAPORE; SPLENOMEGALY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 8544280342     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199605)26:5<318::AID-MPO3>3.0.CO;2-L     Document Type: Article

References (22)

1. Chessells JM: Treatment of childhood ALL: Present issue and further prospects. Blood Rev 6:193-203, 1992.
2. Pui C-H, Crist WM: Biology and treatment of acute lymphoblastic leukemia. J Pediatr 124:491-503, 1994.
3. Chessells JM, Bailey C, Richards SM: Intensification of treatment and survival in all children with lymphoblastic leukemia: Results of UK Medical Research Council trial UKALL X. Lancet 345: 143-148, 1995.
4. Philips M, Richards SM, Chessells JM: AML in children: The cost and benefits of intensive treatment. Br J Haematol 77:473-477, 1991.
5. Magrath I, Gad-el-Mawla N, Lin HP, Epelman S, et al.: Pediatric oncology in less developed countries. In Pizzo PA, Poplack DG (eds): "Principles and Practice of Pediatric Oncology," 2nd ed. Philadelphia: JB Lippincott, pp. 1225-1252, 1993.
6. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the acute leukemias, [French-American-British (FAB) Co-operative Group]. Br J Haematol 33:451-458, 1976.
7. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: The morphological classification of acute lymphoblastic leukemia: Concordance among observers and clinical correlations. Br J Haematol 47:553-561, 1981.
8. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukaemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103:626-629, 1985.
9. Cordell JL, Fallini B, Erber W, Ghosh AK, et al.: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and anti-alkaline phosphatase (APAAP) complexes. J Histochem 32:219-225, 1984.
10. Kuerbitz SJ, Civin CI, Krisscher JP, Ravindranath Y, Steuber CP, Weinstein HJ, Winick N, Ragab AH, Gresik MV, Crist WM: Expression of myeloid associated and lymphoid associated cell-surface antigens in acute myeloid leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:1419-1429, 1992.
11. Steuber CP, Civin C, Krischer J, et al.: A comparison of induction and maintenance therapy for acute non-lymphoblastic leukemia in childhood: Results of a POG study. J Clin Oncol 9:247-258, 1991.
12. SAS/STAT User's Guide, Volume 1 & 2, Version 6, 4th ed. Cary, NC: SAS Institute, 1986.
13. Tiedemann K, Waters KD, Tauro GP, Tucker D, Ekert H: Results of intensive therapy in childhood acute myeloid leukemia incorporating high dose melphalan autologous bone marrow transplantation in first complete remission. Blood 82:3730-3738, 1993.
14. Court-Brown WM, Doll R: Leukemia in childhood and young adult life. Trends in mortality in relation to aetiolgoy. Br J Med 1:981-988, 1961.
15. Pierce MI, Borges WH, Heyn R, Wolff JA, Gilbert ES: Epidemiological factors and survival experience in 1770 children with acute leukemia treated by members of Children's Study Group between 1957 and 1964. Cancer 23:1296-1304, 1969.
16. Grier HR, Weinstein HJ: Acute nonlymphocytic leukemia. In Pizzo PA, Poplack DG (eds): "Principle and Practice of Paediatric Oncology." Philadelphia: J.B. Lippincott, pp. 483-500, 1989.
17. Quah TC, Wong HB, Yip WCL, Vellayppan A, et al.: Treatment and follow-up of acute leukemia in children between 1973 and 1982. J Singapore Pediatr Soc 25:63-69, 1983.
18. Hammond G, Sather H, Bleyer W, et al.: Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia. In Buchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds): "Acute Leukemias." Berlin: Springer-Verlag 1987, pp. 161-166.
19. Morgan E: Cell markers in lymphoma leukemia syndrome in children: A pilot study. Med Pediatr Oncol 12:4-8, 1984.
20. Pullen J, Boyett J, Borowitz M, et al.: How important is common acute lymphocytic leukemia antigen (CALLA) negativity as a prognostic factor in children excluding infants with B-precursor acute lymphocytic leukemia (ALL): A Pediatric Oncology Group (POG) study. Proc Am Soc Clin Oncol 6:151-159, 1987.
21. Vannier JP, Bene MC, Faure GC, et al.: Investigation of the CD10 (cALLA) negative acute lymphoblastic leukemia: Further description of a group with a poor prognosis. Br J Haematol 72:156-172, 1989.
22. Pui C-H, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Mahmoud HH, et al.: Clinical significance of CD10 expression in childhood lymphoblastic leukemia. Blood 7:35-40, 1993.